Mirador Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,536
| Closed | -$297K | – | 202 |
|
|
2024
Q4 | $297K | Buy |
+7,536
| New | +$297K | 0.05% | 158 |
|
|
2024
Q2 | – | Sell |
-2,980
| Closed | -$203K | – | 197 |
|
|
2024
Q1 | $203K | Buy |
+2,980
| New | +$203K | 0.04% | 184 |
|
|
2023
Q1 | – | Sell |
-4,940
| Closed | -$201K | – | 192 |
|
|
2022
Q4 | $201K | Buy |
4,940
+467
| +10% | +$19K | 0.05% | 184 |
|
|
2022
Q3 | $292K | Buy |
4,473
+262
| +6% | +$17.1K | 0.07% | 162 |
|
|
2022
Q2 | $256K | Buy |
4,211
+54
| +1% | +$3.28K | 0.06% | 165 |
|
|
2022
Q1 | $261K | Sell |
4,157
-54
| -1% | -$3.39K | 0.05% | 183 |
|
|
2021
Q4 | $319K | Buy |
+4,211
| New | +$319K | 0.07% | 182 |
|